{"id":"https://openalex.org/W2553404176","doi":"https://doi.org/10.1182/blood.v126.23.2268.2268","title":"Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody","display_name":"Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2553404176","doi":"https://doi.org/10.1182/blood.v126.23.2268.2268","mag":"2553404176"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2268.2268","doi":"https://doi.org/10.1182/blood.v126.23.2268.2268","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2268.2268","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023211233","display_name":"Shauna D Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shauna D Mason","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034135354","display_name":"Jon A. Kenniston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Kenniston","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038298924","display_name":"Stephen R. Comeau","orcid":"https://orcid.org/0000-0003-4281-2026","observed_orcids":["https://orcid.org/0000-0003-4281-2026"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen R Comeau","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006572129","display_name":"Gregory P. Conley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory P Conley","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013765046","display_name":"Niksa Kastrapeli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niksa Kastrapeli","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065224927","display_name":"Kris J. Kopacz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kris J Kopacz","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065563934","display_name":"Allison P Lindberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison P Lindberg","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052238446","display_name":"Janja Cosic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janja Cosic","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018230733","display_name":"Monicah Kivaa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monicah Kivaa","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054935628","display_name":"James A. Qiu","orcid":"https://orcid.org/0000-0002-0418-974X","observed_orcids":["https://orcid.org/0000-0002-0418-974X"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James A Qiu","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018515495","display_name":"Ryan Faucette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Faucette","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083217155","display_name":"Daniel J. Sexton","orcid":"https://orcid.org/0000-0001-9604-5948","observed_orcids":["https://orcid.org/0000-0001-9604-5948"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Sexton","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111440304","display_name":"Christopher TenHoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Tenhoor","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021496734","display_name":"David Gailani","orcid":"https://orcid.org/0000-0001-8142-8014","observed_orcids":["https://orcid.org/0000-0001-8142-8014"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Gailani","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032881100","display_name":"S. Kent Dickeson","orcid":"https://orcid.org/0000-0003-2766-4061","observed_orcids":["https://orcid.org/0000-0003-2766-4061"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Kent Dickeson","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013355417","display_name":"Qiufang Cheng","orcid":"https://orcid.org/0000-0003-1804-3079","observed_orcids":["https://orcid.org/0000-0003-1804-3079"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiufang Cheng","raw_affiliation_strings":["Vanderbilt University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060358952","display_name":"Michael Wallisch","orcid":"https://orcid.org/0000-0002-7133-795X","observed_orcids":["https://orcid.org/0000-0002-7133-795X"]},"institutions":[{"id":"https://openalex.org/I4210094792","display_name":"Aronora (United States)","ror":"https://ror.org/00vrz7m04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wallisch","raw_affiliation_strings":["Aronora Inc., Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aronora Inc., Portland, OR","institution_ids":["https://openalex.org/I4210094792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036237322","display_name":"Andr\u00e1s Gruber","orcid":"https://orcid.org/0000-0001-6212-2247","observed_orcids":["https://orcid.org/0000-0001-6212-2247"]},"institutions":[{"id":"https://openalex.org/I4210094792","display_name":"Aronora (United States)","ror":"https://ror.org/00vrz7m04","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094792"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andras Gruber","raw_affiliation_strings":["Aronora Inc., Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aronora Inc., Portland, OR","institution_ids":["https://openalex.org/I4210094792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108206842","display_name":"Burt Adelman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Burt Adelman","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006543521","display_name":"Andrew E. Nixon","orcid":"https://orcid.org/0000-0002-6090-0583","observed_orcids":["https://orcid.org/0000-0002-6090-0583"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Nixon","raw_affiliation_strings":["Dyax Corp., Burlington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dyax Corp., Burlington, MA","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.24274086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"126","issue":"23","first_page":"2268","last_page":"2268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xiia","display_name":"factor XIIa","score":0.8820000290870667},{"id":"https://openalex.org/keywords/plasma-kallikrein","display_name":"plasma kallikrein","score":0.9660000205039978},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7360000014305115},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.746999979019165},{"id":"https://openalex.org/keywords/antithrombotic-therapy","display_name":"antithrombotic therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/contact-system-activation","display_name":"contact activation","score":0.47200000286102295},{"id":"https://openalex.org/keywords/intrinsic-coagulation-pathway","display_name":"intrinsic coagulation pathway","score":0.7620000243186951},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.6370000243186951},{"id":"https://openalex.org/keywords/cardiopulmonary-bypass","display_name":"cardiopulmonary bypass","score":0.8339999914169312},{"id":"https://openalex.org/keywords/bradykinin","display_name":"bradykinin","score":0.6480000019073486},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.6399999856948853},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C52853521","wikidata":"https://www.wikidata.org/wiki/Q423285","display_name":"Kallikrein","level":3,"score":0.877196192741394},{"id":"https://openalex.org/C2777167447","wikidata":"https://www.wikidata.org/wiki/Q339499","display_name":"Factor XII","level":3,"score":0.8060482144355774},{"id":"https://openalex.org/C152328610","wikidata":"https://www.wikidata.org/wiki/Q7240014","display_name":"Prekallikrein","level":4,"score":0.8001107573509216},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7139530777931213},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.5811319947242737},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.5125529766082764},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5114489793777466},{"id":"https://openalex.org/C2781317560","wikidata":"https://www.wikidata.org/wiki/Q24721273","display_name":"High-molecular-weight kininogen","level":5,"score":0.48706963658332825},{"id":"https://openalex.org/C2777902427","wikidata":"https://www.wikidata.org/wiki/Q6413860","display_name":"Kininogen","level":4,"score":0.4770583212375641},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.4476630687713623},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.42160648107528687},{"id":"https://openalex.org/C182220744","wikidata":"https://www.wikidata.org/wiki/Q7251226","display_name":"Proteases","level":3,"score":0.4159366488456726},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35510173439979553},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32094478607177734},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2866378128528595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2568882405757904},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.169451504945755},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15298864245414734},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07762143015861511}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2268.2268","doi":"https://doi.org/10.1182/blood.v126.23.2268.2268","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2268.2268","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1910638751","https://openalex.org/W2562372870","https://openalex.org/W1752012283","https://openalex.org/W2601468882","https://openalex.org/W2732662074","https://openalex.org/W1972669010","https://openalex.org/W4394622610","https://openalex.org/W2029545735","https://openalex.org/W6921753676","https://openalex.org/W2287232940"],"abstract_inverted_index":{"Abstract":[0],"Factor":[1],"XII":[2],"(FXII),":[3],"also":[4],"called":[5],"Hageman":[6],"Factor,":[7],"is":[8,19,110],"a":[9,152,221,267,273,280,290,302,359,385,390,393,399,412],"key":[10],"component":[11,391],"of":[12,60,92,160,168,174,229,247,259,275,297,316,323,362,392,405,416,422],"the":[13,27,37,48,61,165,205,216,234,242,245,256,312,317,324,330,345,423],"plasma":[14,41,56,86,248,298,408],"contact":[15,428],"system.":[16],"When":[17,195],"blood":[18,109],"exposed":[20],"to":[21,36,103,150,192,250,300,329],"artificial":[22],"surfaces":[23],"or":[24,68,185,375,388],"polyanionic":[25],"substances,":[26],"zymogens":[28],"FXII":[29,67,251],"and":[30,40,85,99,155,177,286,292,320,337,364,366,407],"prekallikrein":[31],"(PK)":[32],"undergo":[33],"reciprocal":[34],"activation":[35],"proteases":[38],"FXIIa":[39,44,84,100,122,169,406,418],"kallikrein,":[42,299],"respectively.":[43],"initiates":[45],"coagulation":[46,187],"through":[47,112,420],"intrinsic":[49],"pathway":[50],"by":[51,264],"activating":[52],"factor":[53],"XI,":[54],"while":[55],"kallikrein":[57,87,249,268,356,409],"mediates":[58],"generation":[59,357],"potent":[62,156,291,414],"vasodilator":[63],"bradykinin.":[64],"Patients":[65],"lacking":[66],"PK":[69],"do":[70],"not":[71,79,132,179],"experience":[72],"abnormal":[73],"bleeding,":[74],"indicating":[75],"these":[76],"proteins":[77],"are":[78,88],"required":[80,89],"for":[81,90],"hemostasis.":[82],"However,":[83],"formation":[91,105],"occlusive":[93],"clots":[94],"in":[95,106,200],"animal":[96],"thrombosis":[97],"models,":[98],"likely":[101],"contributes":[102],"thrombus":[104],"humans":[107],"when":[108],"passed":[111],"extracorporeal":[113],"circuits":[114],"(e.g.":[115],"cardiopulmonary":[116],"bypass).":[117],"These":[118],"observations":[119],"suggest":[120],"that":[121,130,255,311,381],"inhibition":[123,308,404,421],"could":[124,261],"be":[125,262,411],"an":[126,171,226],"effective":[127,353,371],"antithrombotic":[128,257,401],"strategy":[129],"would":[131],"have":[133],"bleeding":[134],"side":[135],"effects":[136],"associated":[137],"with":[138,170,212,266,288],"current":[139],"approved":[140],"anticoagulants.":[141],"We":[142],"used":[143],"our":[144],"human":[145,201],"antibody":[146,158,295,326,347,387],"phage":[147],"display":[148],"library":[149],"identify":[151],"highly":[153],"selective":[154],"monoclonal":[157,294,386],"inhibitor":[159,296],"FXIIa,":[161],"DX-4012.":[162],"DX-4012":[163,203,232,260,276,363,374],"inhibits":[164],"proteolytic":[166],"activity":[167,419],"apparent":[172,313],"Ki":[173,314,334],"~15":[175],"pM,":[176,339],"does":[178],"inhibit":[180],"closely":[181],"related":[182],"sequence":[183],"homologs":[184],"other":[186],"factors":[188],"at":[189,197,354],"concentrations":[190],"up":[191],"1":[193,198],"\u00b5M.":[194],"tested":[196],"\u00b5M":[199],"plasma,":[202,344],"prolonged":[204,233],"activated":[206],"partial":[207],"thromboplastin":[208],"time":[209,218],"(aPTT)":[210],"3.4-fold,":[211],"no":[213,239],"effect":[214,240,258],"on":[215,241],"prothrombin":[217],"(PT).":[219],"In":[220,341],"non-human":[222],"primate":[223],"pharmacokinetic":[224],"study,":[225],"intravenous":[227],"infusion":[228],"10":[230],"mg/kg":[231],"aPTT":[235],"2.4-fold":[236],"but":[237],"had":[238],"PT.":[243],"Given":[244],"importance":[246],"activation,":[252],"we":[253],"reasoned":[254],"augmented":[263],"combination":[265,361],"inhibitor.":[269],"To":[270],"test":[271],"this,":[272],"variant":[274],"was":[277,348],"converted":[278],"into":[279],"single":[281],"chain":[282],"variable":[283],"fragment":[284],"(scFv)":[285],"combined":[287],"DX-2930,":[289,365],"specific":[293],"generate":[301],"\"Morrison":[303],"format\"":[304],"bispecific":[305,325,346,394],"antibody.":[306],"Enzyme":[307],"assays":[309],"determined":[310],"values":[315],"individual":[318],"anti-kallikrein":[319],"anti-FXIIa":[321],"components":[322],"were":[327],"similar":[328],"parent":[331],"molecules":[332],"(apparent":[333],"389":[335],"pM":[336],"73":[338],"respectively).":[340],"contact-activated":[342],"dilute":[343],">":[349],"5":[350],"times":[351],"more":[352,367,370],"preventing":[355],"than":[358,368,372],"1:1":[360],"20-fold":[369],"either":[373,383],"DX-2930":[376],"alone.":[377],"Our":[378],"data":[379],"indicate":[380],"DX-4012,":[382],"as":[384,389,398],"antibody,":[395],"shows":[396],"potential":[397],"novel":[400],"therapy.":[402],"Simultaneous":[403],"may":[410],"uniquely":[413],"method":[415],"blocking":[417],"positive":[424],"feedback":[425],"loop":[426],"during":[427],"activation.":[429],"Disclosures":[430],"Mason:":[431],"Dyax":[432],"Corp:":[433,436,439,442,445,448,451,454,457,460,463,466,469,484,487],"Employment.":[434,437,440,443,446,449,452,455,458,461,464,467,470,472,485,488],"Kenniston:Dyax":[435],"Comeau:Dyax":[438],"Conley:Dyax":[441],"Kastrapeli:Dyax":[444],"Kopacz:Dyax":[447],"Lindberg:Dyax":[450],"Cosic:Dyax":[453],"Kivaa:Dyax":[456],"Qiu:Dyax":[459],"Faucette:Dyax":[462],"Sexton:Dyax":[465],"Tenhoor:Dyax":[468],"Wallisch:Aronora:":[471],"Gruber:Aronora,":[473],"Inc.:":[474],"Employment,":[475],"Equity":[476],"Ownership,":[477],"Patents":[478],"&":[479],"Royalties,":[480],"Research":[481],"Funding.":[482],"Adelman:Dyax":[483],"Nixon:Dyax":[486]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-11-30T00:00:00"}